Til tyktarmskræft var Xeloda også lige så effektivt som 5- FU og folinsyre, idet ca. to tredjedele af patienterne forblev sygdomsfrie i de 3, 8 år, undersøgelsen varede.
In colon cancer, Xeloda was also as effective as 5-FU and folinic acid, with about two-thirds of the patients remaining disease-free throughout the 3.8 years of the study.